An automated drug screening approach gives insight into rare NGLY1 deficiency.
Sometimes, diagnosing and treating an illness is straightforward. Other times, the diagnosis is challenging while the treatment is simple—or vice versa. In the case of a rare disease like NGLY1 Deficiency, both diagnosis and treatment can feel unreachable. The complex challenges of rare diseases prompt outside-the-box approaches—such as the partnership between a rare disease funding body and a fundamental research group. In an article published in G3, Portillo Rodriguez et al. report findings from just such a partnership, outlining a drug screening methodology used to shed light on this rare disease.
N-glycanase 1 (NGLY1) is an enzyme responsible for cleaving sugars from proteins as part of the endoplasmic reticulum-associated degradation (ERAD) pathway, which oversees the breakdown of misfolded proteins. In humans, lack of NGLY1 leads to a condition that baffled clinicians and evaded identification until just a few years ago. NGLY1 Deficiency causes global developmental delay, seizures, floppy body, and an inability to produce tears; fewer than 50 patients with the condition have ever been identified, making research on treatments extremely difficult.
Funding for rare disease research can be hard to come by through standard mechanisms—with so few people affected, scarce research funds are rarely diverted their way. When their daughter Grace was diagnosed with NGLY1 Deficiency, Matt and Kristen Wilsey started the Grace Science Foundation, dedicated to finding a cure for the disease and others like it. In 2017, Grace Science partnered with Perlara, a biotech public benefit corporation (bioPBC) that uses model organisms to discover treatments for rare disease. Their goal is to use high-throughput methodologies in model organisms to identify drugs that could impact the rare disease in question.
The report by Portillo Rodriguez et al. is the first publication to come out of this NGLY1 partnership. The researchers developed an assay that let them efficiently screen a collection of 2,650 compounds for any that might modulate NGLY1-related phenotypes. They first generated a new Drosophila model of NGLY1 Deficiency by introducing a nonsense mutation into Pngl, the fly homolog of NGLY1; this model has a readily identifiable larval size phenotype, which let them perform their screen in 96-well plates with three larvae per well. Each well contained a different drug from the Microsource Spectrum compound library; an automated workflow imaged the plates and quantified the size of the larvae to determine which, if any, of the chemicals modified the mutant phenotype.
The screen produced a single validated hit: 20-hydroxyecdysone (20E), which is an important signaling hormone that drives metamorphosis and molting in arthropods. While 20E is not a good drug candidate for human patients, the implication of the neuroendocrine axis in the pathophysiology of the Drosophila phenotype gives us more information into the mechanism of NGLY1/Pngl than we previously had.
Anything we can learn about the molecular players that contribute to rare disease brings us closer to finding interventions for patients—as does the availability of a validated screening platform. Because model organisms like Drosophila are so amenable to high-throughput screening of whole organism phenotypes, the hope is that approaches like these will bring people with rare diseases one step closer to treatments.
Citation
Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a Drosophila Model of NGLY1 Deficiency
Tamy Portillo Rodriguez, Joshua D. Mast, Tom Hartl, Tom Lee, Peter Sand, Ethan O. Perlstein
G3: Genes, Genomes, Genetics July 1, 2018 vol. 8 no. 7 2193-2204;
https://doi.org/10.1534/g3.118.300578
http://www.g3journal.org/content/8/7/2193
Scientific Editor and Programs Manager. Genetics and Molecular Biology PhD. Find me on Twitter: @_sbay
View all posts by Sarah Bay »Read more in
-
Hongyu Zhao joins GENETICS as new Senior Editor
A new senior editor is joining GENETICS in the Statistical Genetics and Genomics section. We’re excited to welcome Hongyu Zhao to the editorial team. Hongyu ZhaoSenior Editor Hongyu Zhao is the Ira V. Hiscock Professor of Biostatistics, Professor of Genetics, and Professor of Statistics and Data Science at Yale University. He received his BS in…
-
GSA Member Julio Molina Pineda Receives DeLill Nasser Award, Shines at TAGC 2024
“At any career stage, the GSA membership is an amazing investment for any genetics professional!” Julio Molina Pineda is a PhD Candidate in Cell and Molecular Biology and a Research Assistant at the University of Arkansas, and a Doctoral Academy Fellow at the Lewis Lab. In 2023, Julio was awarded the DeLill Nasser Award for…
-
In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation
Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…
-
Congratulations to the #Fungal24 Poster Award winners!
We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…
-
Poster presentation tips for TAGC 2024
You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…
-
Maximize your TAGC 2024 experience
A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…
-
Early Career Leadership Spotlight: Sarah Petrosky
We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…
-
TAGC 2024 Early Career Award Winners
GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024. Don’t miss the opportunity…
-
Preeminent geneticists recognized with revamped GSA Awards
In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…
-
Fly Board funds outreach programs to spread the word about Drosophila research
In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…
-
New members of the GSA Board of Directors: 2024–2026
We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…